Response Assessment in Myeloma: Practical Manual on Consistent reporting in an era of dramatic therapeutic advances
Abstract
The understanding and treatment of multiple myeloma have dramatically improved in the last years. However, accurate assessment of the response of myeloma to therapy and its subsequent relapse remains a difficult task. Criteria have changed over time and new parameters have recently been incorporated to evaluate the minimal residual disease status. We present a practical approach to assess response and relapse/progression in myeloma in the context of its treatment. A robust reporting schema is crucial to correctly evaluate any treatment protocol and do cross trial comparisons.
| Origin | Files produced by the author(s) |
|---|